On the basis of these results, and as reductases are present
in a great variety of plants and vegetables,9 carrots (Daucus
carota) were selected to reduce piperidinones 1 and 2 because
this plant usually gives good results10 (Scheme 3).
Scheme 1
.
Retrosynthesis Analysis of Optically Active
Piperidines of Type A
Scheme 3. Reduction of ꢀ-Keto-ester by Daucus carota
agents as well as the isolation of pure ꢀ-hydroxyesters in
high yields from the reaction or fermentation media.6
Recently, plant cell culture and plant roots have been used
in reductions. These biocatalysts are active in aqueous media
under mild, economically viable conditions, and they are
more eco-compatible than organometallics.7 The most com-
mon biocatalyst used to selectively reduce the ketone in
ketoesters is baker’s yeast.8 Appropriately, the reduction of
N-benzyl-ꢀ-piperidinone ester 1 using baker’s yeast was
initially examined. When compound 1 (2 mmol) was treated
with baker’s yeast (4 g) in the presence of sucrose (5 g) in
water (60 mL) at 37 °C for 24 h, the corresponding
ꢀ-hydroxyester 3 was not detected. On the contrary, when
N-Boc-ꢀ-ketoester 2 was treated under the same conditions
used for 1, the expected cis-4-hydroxypiperidine ester 4 was
isolated in 80% yield but, very disappointgly, in its racemic
form (Scheme 2). We have to point out that the reduction of
Compound 1 (2 mmol) was treated with carrots (140 g)
in water (600 mL) at rt, and after 48 h, K2CO3 was added
(pH ) 10) before extraction [the reaction media was acidic
(pH ) 5)] and two hydroxyesters 3′ (cis-isomer) and 3′′
(trans-isomer) were isolated in 80% yield in a ratio of
70/30 in favor of the trans-isomer. Both isomers 3′ and 3′′
were obtained with an identical enantiomeric excess (ee )
94%). N-Boc-piperidone ester 2 was also reduced by carrots
and 4′ (cis-isomer) as well as 4′′ (trans-isomer) were isolated
in 91% yield in a diastereomeric ratio of 60/40 in favor of
the cis-isomer. Compounds 4′ and 4′′ were obtained with a
similar enantiomeric excess of 91%. The absolute configu-
ration of the stereogenic centers were determined by
comparison of the [R]D of compounds 4′ and 4′′ descibed in
the literature.11
Scheme 2. Reduction of ꢀ-Keto-ester by Baker’s Yeast
We have to point out that the ratio 4′/4′′ depends on the pH
of the solution. When the reduction was achieved in the presence
(7) (a) Wong, C. H.; Whitesides, G. M. In Enzymes in Synthetic Organic
Chemistry; Pergamon Press: Oxford, 1994. (b) Drauz, K.; Waldmann, H.
In Enzymes Catalysis in Organic Synthesis; VCH: New York, 1995; Vols.
I, II, and III. (c) Faber, K. In Biotransformations in Organic Chemistry,
5th ed.; Springer: Berlin, Heidenberg, Germany, 2004. (d) Gavrilescu, M.;
Chisti, Y. Biotechnol. AdV. 2005, 23, 471–499. (e) Nakamura, K.; Matsuda,
T. Curr. Org. Chem. 2006, 10, 12217–1246.
(8) (a) Padhi, S. K.; Kaluzna, I. A.; Buisson, D.; Azerad, R.; Stewart,
J. D. Tetrahedron: Asymmetry 2007, 18, 2133–2138. (b) Alonso, E. R.;
Tehrani, K. A.; Boelens, M.; De Kimpe, N. Syn. Lett. 2005, 11, 1726–
1730. (c) Yadav, J. S.; Nanda, S.; Reddy, P. T.; Rao, A. B. J. Org. Chem.
2002, 67, 3900–3903. (d) Bertau, M.; Buerli, M.; Hungerbuehler, E.;
Wagner, P. Tetrahedron: Asymmetry 2001, 12, 2103–2108. (e) Miya, H.;
Kawada, M.; Sugiyama, Y. B. Biotechnol. Biochem. 1996, 60, 760–764.
(f) Seebach, D.; Roggo, S.; Maetzke, T.; Braunschweiger, H.; Cercus, J.;
Krieger, M. HelV. Chim. Acta 1987, 70, 1605–1615. (g) Herradon, B.;
Seebach, D. HelV. Chim. Acta 1989, 72, 690–714. (h) Kometani, T.;
Kitatsuji, E.; Matsuno, R. Chem. Lett. 1989, 1465–1466. (i) Buisson, D.;
Azerad, R. Tetrahedron Lett. 1986, 27, 2631–2634. (j) Spiliotis, V.;
Papahatjis, D.; Ragoussis, N. Tetrahedron Lett. 1990, 31, 1615–1616.
(k) Deol, B. S.; Ridley, D. D.; Simpson, G. W. Aust. J. Chem. 1976, 29,
2459–2467.
N-Boc-ꢀ-ketoester 2 by baker’s yeast was already described
in the literature to provide cis-4-hydroxyester 4 with a good
enantiomeric excess,5a but these results have been contra-
dicted by Bols and Willert5b who have reported the formation
of 4 as a racemate which confirmed our results.
(6) (a) Kitamura, M.; Ohkuma, T.; Tokunaga, M.; Noyori, R. Tetrahe-
dron Asymmetry 1990, 1, 1–4. (b) Ratovelomanana-Vidal, V.; Genêt, J. P.
J. Organomet. Chem. 1998, 163–172. (c) Servi, S. Synthesis 1990, 1.
(d) Kaouwka, W. S.; Sabucky, M. J.; Vinayand, D. J. Chem. Soc., Chem
Commun. 1972, 10–12. (e) Hajos, A. In Complex Hydrides and Related
Reducing Agents In Organic Synthesis; Elsevier: New York, 1979.
(f) Bosnich, B.; Fryzuk, M. D.; Geoffray, G. L. In Topics in Inorganic and
Organomettalic Stereochemistry; Wiley: New York, 1981; pp 119-125.
(g) Baiker, A. J. Mol. Catal. A: Chem. 2000, 163, 205–220. (h) Kroutil,
W.; Mang, H.; Edegger, K.; Faber, K. Curr. Opin. Chem. Biol. 2004, 8,
120–126. (i) Engelking, H.; Pfaller, R.; Wich, G.; Weuster-Botz, D. Enzyme
Microb. Technol. 2006, 38, 536–544.
(9) Nishida, T.; Miyafuji, A.; Ito, Y. N.; Katsuki, T. Tetrahedron Lett.
2000, 41, 7053–7058.
(10) Review: Blanchard, N.; Van de Weghe, P. Org. Biomol. Chem.
2006, 4, 2348–2353.
(11) Knight, D. W.; Lewis, N.; Share, A. C.; Haigh, D. Tetrahedron
Asymmetry 1993, 625–628.
1246
Org. Lett., Vol. 11, No. 6, 2009